Peninsula biotech lands $150 million deal to tackle brain diseases
Alzheimer's disease and amyotrophic lateral sclerosis, or Lou Gehrig's disease, are two potential deals of a multi-year deal between a Peninsula company and Celgene.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: ALS | Alzheimer's | Biotechnology | Brain | Health Management | Neurology | Pharmaceuticals